Limiting damage to healthy tissue
Inactivation of T cells limits damage to healthy tissue.
The tumor escapes detection
Inactivation of T cells reduces tumor cell killing
Immuno-oncology therapies harness the immune response to fight tumors
Blocking PD-L1 enables cytotoxic T cells to actively remove tumor cells
Want to hear more about PD-L1 IHC 28-8 pharmDx?
Contact your local sales representative
Product Information